How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

Dragonfly Initiates Phase 1/1b Study of its IL-2 Immunotherapy

calendar_today December 5, 2023 person maura169 domain dragonfly-therapeutics

The company announces the first patient dosed in a Phase 1/1b clinical trial evaluating its novel IL-2 cytokine, DF6215, the seventh…

open_in_new Read original post